EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA






Lancet 355(9197): 41-42

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA

Hepatitis C virus (HCV) was transmitted by transfusion of a platelet concentrate made from an anti-HCV and HCV-PCR-negative blood donation. Even a negative nucleic acid amplification test cannot completely prevent transmission of HCV.

Accession: 010743991

PMID: 10615893

DOI: 10.1016/S0140-6736(99)04719-4

Download PDF Full Text: Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA



Related references

Sobata, R.; Shinohara, N.; Matsumoto, C.; Uchida, S.; Igarashi, S.; Hino, S.; Satake, M.; Tadokoro, K., 2015: First report of human immunodeficiency virus transmission via a blood donation that tested negative by 20-minipool nucleic acid amplification in Japan. Transfusion 54(9): 2361-2362

Vermeulen, M.; Lelie, N.; Sykes, W.; Crookes, R.; Swanevelder, J.; Gaggia, L.; L.R.ux, M.; Kuun, E.; Gulube, S.; Reddy, R., 2009: Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. In 2005, the South African National Blood Service introduced individual-donation (ID) nucleic acid test (NAT) screening for human immunodeficiency virus (HIV) RNA, hepatitis C virus (HCV) RNA, and hepatitis B virus (HBV) DNA. At the same time the...

Japanese Red Cross Nat Screening Research Group, 2000: Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. This study described a program for and the results of a nationwide nucleic acid amplification testing (NAT) screening for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1) by multiplex reagent with a...

Bamaga, M.S.; Azahar, E.I.; Al-Ghamdi, A.K.; Alenzi, F.Q.; Al-Enzi, F.Q.; Farahat, F.M., 2010: Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. To investigate the performance of hepatitis B virus polymerase chain reaction (HBV PCR) using one of the commercial methods used around the world to screen for HBV in some blood donors where other conventional serological assays have limitations t...

Stramer, S.L.; Zou, S.; Notari, E.P.; Foster, G.A.; Krysztof, D.E.; Musavi, F.; Dodd, R.Y., 2012: Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?. The American Red Cross implemented hepatitis B virus (HBV) minipool (MP)-nucleic acid testing (NAT) in June 29, in addition to existing tests for hepatitis B surface antigen (HBsAg) and antibodies to hepatitis B core antigen (anti-HBc). The value...

Yoo, S.Hyung.; Hong, S.Hee.; Jung, S.Rah.; Park, S.Jin.; Lee, N.Kyung.; Kim, S.Nam.; Kang, S.Mo.; Min, H.Ki.; Park, S.Nie.; Hong, S.Hwa., 2006: Application of bovine viral diarrhoea virus as an internal control in nucleic acid amplification tests for hepatitis C virus RNA in plasma-derived products. Plasma-derived products are produced from plasma via fractionation and chromatography techniques, but can also be produced by other methods. In the performance of nucleic acid amplification tests (NAT) with plasma-derived products, it is necessary...

Offergeld, R.; Faensen, D.; Ritter, S.; Hamouda, O., 2005: Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Blood and plasma donations in Germany are collected by several institutions, namely the German Red Cross, community and hospital-based blood services, private blood centres, commercial plasma donation sites and transfusion services of the army. Al...

Mine, H.; Emura, H.; Miyamoto, M.; Tomono, T.; Minegishi, K.; Murokawa, H.; Yamanaka, R.; Yoshikawa, A.; Nishioka, K., 2003: High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Nationwide nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) of blood donated voluntarily after serological screening was implemented on July 1st 1999 for...

Mine, H.; Emura, H.; Miyamoto, M.; Tomono, T.; Minegishi, K.; Murokawa, H.; Yamanaka, R.; Yoshikawa, A.; Nishioka, K., 2003: High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. Nationwide nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) of blood donated voluntarily after serological screening was implemented on July 1st 1999 for...

Gou, H.; Pan, Y.; Ge, H.; Zheng, Y.; Wu, Y.; Zeng, J.; Yang, Z.; Pan, T.; Cun, W.; Zhou, G.; Fang, G.; Zhang, J.; Zhang, K.; Zhang, R.; Sun, Y.; Xie, J.; Li, J.; Wang, L., 2015: Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors. This multicenter study was performed to evaluate the efficiency of a multiplex individual-donation nucleic acid amplification technology (ID-NAT) and discriminatory testing algorithm for detecting hepatitis B virus (HBV) infection in Chinese blood...